Research hero image

Research

KCA-funded research shows how family genetics impact kidney cancer thumbnail image

KCA-funded research shows how family genetics impact kidney cancer

KCA, Research
Dr. Salvatore La Rosa, KCA Chief Scientific Officer I’m excited to highlight a new study spearheaded by Dr. Ritesh Kotecha from Memorial Sloan Kettering Cancer Center that describes how renal cell carcinoma (RCC) patients’ genetic ancestry (GA) – which is the information about people who are biologically related – is correlated with clinical, histological, and molecular data across different ancestral…
Read More
Belzutifan results

Belzutifan results "practice changing" at ESMO 2023

Research
Three analyses of the LITESPARK trial examining the hypoxia-inducible factor 2a (HIF-2a) belzutifan (Welireg) showed efficacy and benefit for this novel therapy over comparator treatments in advanced clear cell renal cell carcinoma (RCC) as well as at multiple doses. https://www.youtube.com/watch?v=4rwHg9yazz4 “I believe [LITESPARK-005] is a practice-changing study and I do want belzutifan to be made available for patients,” said Dr.…
Read More
Exercise and Sickle Cell Trait: New research unveils the connection thumbnail image

Exercise and Sickle Cell Trait: New research unveils the connection

KCA, Research
The KCA recently partnered with two advocacy groups on a blog post examining the relationship between exercise and sickle cell trait. https://sickcells.org/blog/exercise-and-sickle-cell-trait-understanding-risks-and-embracing-wellness/ This blog post appears at Sick Cells, a national non-profit advocacy group for sickle cell disease (SCD), and was co-authored with our Affiliate Partner organization the Chris “CJ” Johnson Foundation, a global non-profit supporting individuals diagnosed with renal…
Read More
Q&A: Dr. Niki Zacharias Millward, Chromophobe RCC Focus Award winner thumbnail image

Q&A: Dr. Niki Zacharias Millward, Chromophobe RCC Focus Award winner

KCA, Research
Dr. Niki Zacharias Millward, PhD,  received a 2023 KCA Chromophobe RCC Focus Award for research on “Leveraging patient-derived xenograft models to identify and therapeutically target metabolic hallmarks of chromophobe renal cell carcinoma.” Dr. Millward is an assistant professor in the Department of Urology - Research, Division of Surgery at MD Anderson Cancer Center in Houston, Texas. We spoke with Dr.…
Read More
1 … 5 6 7 8 9 … 17